A discussion on regulation during the Health Privacy Summit in Washington considered emerging issues that will confront the industry, consumers and government regulators.

On the table, for instance, was the right of patients to have some degree of control over their de-identified data. The HIPAA rules are set up to not only permit use of such data, but to actually encourage its use, noted Marcy Wilder, a privacy and information management attorney at the law firm Hogan Lovells. However, if there is a way to recover the data, it cannot be considered de-identifiable.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access